CSS
LIMNW

Cubist Systematic Strategies’s Liminatus Pharma Warrants LIMNW Stock Holding History

Cubist Systematic Strategies’s Portfolio LIMNW Stock Details LIMNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.33K Hold
15,778
– – ﹤0.01% 2941
2025
Q2 		$3.79K Buy
+15,778
New +$3.1K ﹤0.01% 2861

Other funds holding LIMNW

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

Cubist Systematic Strategies's LIMNW Position: Q3 2025 in Review

Cubist Systematic Strategies held its Liminatus Pharma Warrants (LIMNW) position steady in Q3 2025 at 15,778 shares worth $2.33K. The position accounts for ﹤0.01% of the portfolio, ranked #2941.

Cubist Systematic Strategies first reported a position in LIMNW in Q2 2025 and has held it in 2 quarters since. The position peaked at $3.79K in Q2 2025. 26 funds tracked by Wall St. Rank hold LIMNW as of Q3 2025.

  • Cubist Systematic Strategies held 15,778 shares of Liminatus Pharma Warrants worth $2.33K as of Q3 2025.
  • Cubist Systematic Strategies left its Liminatus Pharma Warrants share count unchanged in Q3 2025.
  • Liminatus Pharma Warrants made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2941 holding.
  • Cubist Systematic Strategies first reported a position in Liminatus Pharma Warrants in Q2 2025 and has held it in 2 quarters since.
  • Cubist Systematic Strategies's Liminatus Pharma Warrants position peaked at $3.79K in Q2 2025.
  • 26 funds tracked by Wall St. Rank held Liminatus Pharma Warrants as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.